Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
I got the vaccine, and it triggered a chronic case of Gillian Barre Syndrome; Bedridden; I can't move at all; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: I got the vaccine, and it triggered a chronic case of Gillian Barre Syndrome) (serious criteria GSK medically significant), bedridden (Verbatim: Bedridden) and mobility decreased (Verbatim: I can't move at all). The outcome of the guillain barre syndrome, bedridden and mobility decreased were not resolved. It was unknown if the reporter considered the guillain barre syndrome, bedridden and mobility decreased to be related to Shingles vaccine. The company considered the guillain barre syndrome to be unrelated to Shingles vaccine. It was unknown if the company considered the bedridden and mobility decreased to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 02-AUG-2025 This case was reported by a patient via interactive digital media. Consumer reported that got the vaccine, and it triggered a chronic case of Gillian Barre Syndrome. He or she also reported that become so weak and can't move at all, and the treatment for Gillian Barre had started to affect my kidneys. He or she was now completely bedridden. The follow-up could not be possible as no contact details were available.; Sender's Comments: A case of Guillain-Barre syndrome, an unknown time after receiving Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.